| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/09/2002 | CA2292012C Inhibitor of helicobacter pylori colonization |
| 07/09/2002 | CA2270124C 9a,11b-dehydro derivatives of 9-oxime-3-keto-6-0-methylerythromycin |
| 07/09/2002 | CA2244519C C-4":substituted macrolide antibiotics |
| 07/09/2002 | CA2099866C Antibiotic a 40926 ester derivatives |
| 07/09/2002 | CA1341375C Compositions and methods for the treatment and prevention of gram-negative bacterial infections |
| 07/04/2002 | WO2002052002A2 Immunomodulatory polynucleotides and methods of using the same |
| 07/04/2002 | WO2002051999A1 Novel atopic dermatitis-associated gene and proteins |
| 07/04/2002 | WO2002051866A2 Antibacterial treatments |
| 07/04/2002 | WO2002051865A2 Proteinic antigens inducing antibodies neutralising hiv virus |
| 07/04/2002 | WO2002051847A1 Processes for preparing calanolide a and intermediates thereof |
| 07/04/2002 | WO2002051843A1 Novel purine derivatives, preparation method and use as medicines |
| 07/04/2002 | WO2002051836A1 Dipeptidyl peptidase iv inhibitor |
| 07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051819A2 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them |
| 07/04/2002 | WO2002051814A1 Benzoylpyridazines |
| 07/04/2002 | WO2002051442A1 Concomitant drugs |
| 07/04/2002 | WO2002051438A2 Use of repulsive guidance molecule (rgm) and its modulators |
| 07/04/2002 | WO2002051435A2 New therapeutic uses of smr1 peptides |
| 07/04/2002 | WO2002051434A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | WO2002051430A2 Methods of modulating toll-related receptor (trr) signaling |
| 07/04/2002 | WO2002051427A1 Improved and stable extract from hypericum perforatum l., method for the production thereof and its use as a topical medicament |
| 07/04/2002 | WO2002051425A1 Remedies for hepatitis c |
| 07/04/2002 | WO2002051419A2 A pharmaceutical composition containing benzopyrano-oxopyrimidotetrahydrothiazine and its use in the treatment of hiv |
| 07/04/2002 | WO2002051414A1 Medicinal compositions for oral use |
| 07/04/2002 | WO2002051413A2 Macrocyclic anti-viral compounds |
| 07/04/2002 | WO2002051408A1 Azole compounds as anti-fungals agents |
| 07/04/2002 | WO2002051404A1 Compositions for oral use |
| 07/04/2002 | WO2002051356A2 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
| 07/04/2002 | WO2002051254A1 Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk |
| 07/04/2002 | WO2002051237A2 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | WO2002051233A2 Universal antimicrobial treatment |
| 07/04/2002 | WO2002030259A3 Disease prevention by reactivation of the thymus |
| 07/04/2002 | WO2002018354A8 Oxazolidinones and their use as antibacterial agents |
| 07/04/2002 | WO2002017917A8 Manzamines for treatment of drug resistant infection |
| 07/04/2002 | WO2002015904B1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections |
| 07/04/2002 | WO2002012346A8 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 07/04/2002 | WO2002002139A3 Methods and composition for oral vaccination |
| 07/04/2002 | WO2001098275A3 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 07/04/2002 | WO2001091682A8 Composition and applicator for topical substance delivery |
| 07/04/2002 | WO2001090148A8 Neurotransmitter transporters |
| 07/04/2002 | WO2001078768A3 Targeted vaccine delivery systems |
| 07/04/2002 | WO2000069891A9 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/04/2002 | WO2000022430A9 Neisseria genomic sequences and methods of their use |
| 07/04/2002 | US20020086981 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 07/04/2002 | US20020086905 Gel for treatment of skin diseases and for disinfection of the skin |
| 07/04/2002 | US20020086891 Substituted benzo(b)thiophenes or benzoisothiazoles which inhibit 2,3-oxidosqualene-lanosterol cyclase which is required for the biosynthesis of cholesterol, ergosterol and other sterols |
| 07/04/2002 | US20020086852 Method for treating respiratory disorders associated with pulmonary elastic fiber injury |
| 07/04/2002 | US20020086837 Acne vaccine |
| 07/04/2002 | US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC |
| 07/04/2002 | US20020086813 Mutants of streptococcal toxin a and methods of use |
| 07/04/2002 | US20020086403 Polypeptide for use in the treatment and prevention of viral infections and cancer |
| 07/04/2002 | US20020086385 Nucleotide sequences coding enzyymatic polypeptide for use in prevention of bacterial infection; bactericides |
| 07/04/2002 | US20020086304 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 07/04/2002 | US20020086297 Gene alteration in the gene for the Gbeta3-subunit of the human G protein |
| 07/04/2002 | US20020086063 Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations |
| 07/04/2002 | US20020086059 Dissolving solid material in dimethyl ether under a pressure and heating; reducing pressure on solution to precipitate the solid material as pulverous formulation and to expand dimethyl ether into a gas, separating |
| 07/04/2002 | US20020086051 For delivering drug directly to interior portions of the body of a mammalian organism, such as to the eye |
| 07/04/2002 | US20020086037 For use in therapy of bacterial infections, cancer; in vaccines |
| 07/04/2002 | US20020086034 Compositions and methods for treating viral infections |
| 07/04/2002 | US20020086033 Pestivirus mutants and vaccines containing the same |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | US20020086023 Streptococcal streptolysin S vaccines |
| 07/04/2002 | US20020086020 Method for improving the half-life of soluble viral receptors on mucosal membranes |
| 07/04/2002 | US20020086012 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein |
| 07/04/2002 | US20020086008 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 07/04/2002 | US20020086000 Stimulation of thymus for vaccination development |
| 07/04/2002 | US20020085999 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 07/04/2002 | US20020085615 Differential scanning calorimeter |
| 07/04/2002 | DE10065710A1 Arzneimittel enthaltend ein Polyamin als Wirksubstanz A medicament comprising a polyamine as the active substance |
| 07/04/2002 | CA2437209A1 Remedies for hepatitis c |
| 07/04/2002 | CA2436739A1 Combination agent |
| 07/04/2002 | CA2433266A1 Compositions for oral use |
| 07/04/2002 | CA2433259A1 Azole compounds as anti-fungals agents |
| 07/04/2002 | CA2433220A1 Novel purine derivatives, preparation method and use as medicines |
| 07/04/2002 | CA2433138A1 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them |
| 07/04/2002 | CA2433090A1 Dipeptidyl peptidase iv inhibitor |
| 07/04/2002 | CA2432927A1 Antibacterial treatments |
| 07/04/2002 | CA2432715A1 Novel atopic dermatitis-associated gene and proteins |
| 07/04/2002 | CA2432542A1 Methods of modulating toll-related receptor (trr) signaling |
| 07/04/2002 | CA2432527A1 Medicinal compositions for oral use |
| 07/04/2002 | CA2431916A1 New therapeutic uses of smr1 peptides |
| 07/04/2002 | CA2431913A1 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | CA2430930A1 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | CA2430691A1 Immunomodulatory polynucleotides and methods of using the same |
| 07/03/2002 | EP1219711A2 Lawsonia intracellularis vaccine |
| 07/03/2002 | EP1219709A1 Nucleozymes |
| 07/03/2002 | EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1) |
| 07/03/2002 | EP1219635A2 Chlamydia pneumoniae antigenes |
| 07/03/2002 | EP1219630A1 Immunopotentiating compositions |
| 07/03/2002 | EP1219618A1 Quinolinecarboxylic acid derivative or its salt |
| 07/03/2002 | EP1219607A1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 07/03/2002 | EP1219605A1 Urea compounds, process for producing the same and use thereof |
| 07/03/2002 | EP1219294A1 Melanin concentrating hormone antagonists |
| 07/03/2002 | EP1218544A1 Methods for identifying rna binding compounds |
| 07/03/2002 | EP1218540A2 Transposon mediated differential hybridisation |
| 07/03/2002 | EP1218514A1 Designing immunogens |
| 07/03/2002 | EP1218511A1 Antimicrobial compositions |
| 07/03/2002 | EP1218507A1 Monoclonal antibody 3f1h10 neutralising vhsv (viral haemorrhagic septicaemia virus) |
| 07/03/2002 | EP1218502A2 Nicotinic acetylcholine receptor : alpha10 subunit |
| 07/03/2002 | EP1218499A2 RESCUE OF MUMPS VIRUS FROM cDNA |